CTI Life Sciences Fund makes venture capital investments in high-quality emerging life science companies at the pre-clinical and clinical development stages. Our main guiding principle is to catalyze, transform and invest in the future of life sciences across Canada, the U.S., and Europe. CTI Life Sciences Fund strategy revolves around the "Inception-2-Inflection" concept. We will invest from birthing new companies to more advanced-clinical-stage organizations. The Fund is driven by a complementary management team providing a deep scientific knowledge base, board management and governance experience, and business acumen. We seek highly differentiated and scalable ideas, that we will chaperone forward to growth.
29
Total Investments
20
Portfolio Companies
-
Exits
-
Industries
General Information
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About CTI Life Sciences Fund
Recent Investments (29)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series C | •••••• | Apr 2025 | |
| Grant | •••••• | Oct 2024 | |
| Venture Round | •••••• | Mar 2024 | |
| Series D | •••••• | Sep 2023 | |
| Series A | •••••• | May 2022 | |
|
|
Seed | •••••• | Apr 2022 |
|
|
Seed Round | •••••• | Oct 2020 |
|
|
Seed Round | •••••• | Aug 2020 |
|
|
Seed Round | •••••• | Jun 2020 |
|
|
Series D | •••••• | Mar 2020 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.